Title : SNX-25a, a novel Hsp90 inhibitor, inhibited human cancer growth more potently than 17-AAG.

Pub. Date : 2014 Jul 18

PMID : 24879994






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 17-Allylamino-17-demethoxygeldanamycin (17-AAG), a typical Hsp90 inhibitor derived from geldanamycin (GA), has entered Phase III clinical trials for cancer therapy. geldanamycin N-methylpurine DNA glycosylase Homo sapiens
2 17-Allylamino-17-demethoxygeldanamycin (17-AAG), a typical Hsp90 inhibitor derived from geldanamycin (GA), has entered Phase III clinical trials for cancer therapy. geldanamycin N-methylpurine DNA glycosylase Homo sapiens